Related Experiment Video
Updated: Sep 26, 2026

Mapping Hepatic Stellate Cell Morphology in Mouse Models of Liver Fibrosis
Published on: February 13, 2026
[Liver hemosiderosis in chronic hepatitis]
O A Smirnov1, N M Anichkov, V G Radchenko
1I.M. Mechnikov Saint-Petersburg State Medical Academy, 195067, Saint-Petersburg.
Insights
Liver hemosiderosis, a marker of iron overload, is common in chronic hepatitis B, C, and alcoholic liver disease. Its presence is linked to more severe disease and reduced treatment effectiveness.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Context:
- Liver hemosiderosis (LH) is a condition indicating organ iron overload.
- Chronic hepatitis (CH) encompasses viral (B, C) and alcoholic (AL) etiologies.
- Understanding LH prevalence and associations is crucial for patient management.
Purpose:
- To investigate the incidence and clinical associations of liver hemosiderosis in patients with chronic hepatitis.
- To evaluate the impact of LH on disease severity and treatment efficacy.
Summary:
- Liver hemosiderosis was present in 39.4% of patients with chronic hepatitis (B, C, or AL).
- Incidence rates were 33.3% in CH B, 49.3% in CH C, and 48.7% in AL.
- LH correlated with longer disease duration, higher activity, and advanced hepatic cirrhosis.
Impact:
- Liver hemosiderosis is associated with more severe chronic hepatitis and alcoholic liver disease.
- Reaferon therapy showed reduced efficacy in hepatitis B and C patients with LH.
- These findings highlight LH as secondary hemosiderosis, impacting therapeutic outcomes.
Abstract:
Liver hemosiderosis (LH) was studied in chronic hepatitis (CH) B and C and CH of other and alcoholic (AL) etiology. LH was present in 122 patients (a study group) and was absent in 188 patients (a comparison group). LH is considered to be a marker of organ iron overload. The total incidence of LH was 39.4 +/- 2.7%, including 33.3 +/- 5.6% in LH-B, 49.3 +/- 5.8% in LH-C, and 48.7 +/- 8.0% in AL. The association with LH was characterized by a longer duration of the disease, by a higher activity and degree of hepatic cirrhosis. The efficiency of reaferon therapy was lower in hepatitis B and C in the presence of LH. These forms of the disease are considered to be secondary hemosiderosis.
Related Concept Videos
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Lifecycle of Erythrocytes
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Portal Hypertension
